AGREEMENT AND PLAN OF MERGER by and among ABBVIE INC., SYMPHONY HARLAN LLC, SYMPHONY HARLAN MERGER SUB INC. and CEREVEL THERAPEUTICS HOLDINGS, INC. Dated as of December 6, 2023Agreement and Plan of Merger • December 7th, 2023 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 7th, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of December 6, 2023, by and among AbbVie Inc., a Delaware corporation (“Parent”), Symphony Harlan LLC, a Delaware limited liability company and a wholly owned Subsidiary of Parent (“Intermediate Holdco”), Symphony Harlan Merger Sub Inc., a Delaware corporation and a direct wholly owned Subsidiary of Intermediate Holdco (“Merger Sub”), and Cerevel Therapeutics Holdings, Inc., a Delaware corporation (the “Company”).
SUPPORT AGREEMENTSupport Agreement • December 7th, 2023 • Cerevel Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 7th, 2023 Company Industry JurisdictionThis SUPPORT AGREEMENT (this “Agreement”), dated as of December 6, 2023, is by and among AbbVie Inc., a Delaware corporation (“Parent”), Symphony Harlan LLC, a Delaware limited liability company and a wholly owned Subsidiary of Parent (“Intermediate Holdco”), Symphony Harlan Merger Sub Inc., a Delaware corporation and a direct wholly owned Subsidiary of Intermediate Holdco (“Merger Sub”), and BC Perception Holdings, LP, a Delaware limited partnership (the “Stockholder”).